Tg Therapeutics (TGTX) Free Cash Flow (QoQ) (2011 - 2026)
Tg Therapeutics (TGTX) Free Cash Flow (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Tg Therapeutics | 8.09 Bn | 8.02 Bn | 171.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -191.59% |
| Dec 31, 2025 | 184.33% |
| Sep 30, 2025 | -414.21% |
| Jun 30, 2025 | 125.73% |
| Mar 31, 2025 | -11.99% |
| Dec 31, 2024 | -109.85% |
| Sep 30, 2024 | -320.90% |
| Jun 30, 2024 | 167.45% |
| Mar 31, 2024 | 37.87% |
| Dec 31, 2023 | -115.78% |
| Sep 30, 2023 | 299.27% |
| Jun 30, 2023 | 29.88% |
| Mar 31, 2023 | -150.92% |
| Dec 31, 2022 | 30.80% |
| Sep 30, 2022 | 29.76% |
| Jun 30, 2022 | 28.50% |
| Mar 31, 2022 | 21.03% |
| Dec 31, 2021 | -29.29% |
| Sep 30, 2021 | -11.49% |
| Jun 30, 2021 | 25.89% |